focus -WSS

focus

author：comprehensive 2025-08-23 06:45:23 - browse：4

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Testing GLP

WSS

Why health care costs have stayed mostly flat since 2010

Medical devices makers are asking for forgiveness, not permission

Yancopoulos of Regeneron works to expand Dupixent success

Virtual care provider acquires bankrupt Pear's prescription apps

Violet CEO on training clinicians to promote more inclusive care

What Kate Middleton's cancer revelation might teach the world

hotspot

focus

explore

ChatGPT in medicine: STAT answers readers' burning questions

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Hepatitis C has a cure — but many Americans still lack access to it

SNAP should offer more nutrition education

Activists slam private health insurers over coverage restrictions

HCA sued by state AG for quality issues at Mission Health

Trump demands the U.S. pay no more for drugs than other countries … again

Christmas in the PICU brings some surprising joy

The cancer drug shortage isn’t new — and neither are the solutions

Bring on the sabbaticals for nurses

Wikipedia

Medicare drug price negotiation hasn't dried up venture capital

Medicare Advantage insurers pressure Biden for bigger payments

SNAP should offer more nutrition education

Why health care costs have stayed mostly flat since 2010

Editas, Vertex strike deal on CRISPR

Medical devices makers are asking for forgiveness, not permission

focus

knowledge

focus

focus